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Abstract
Background: Mild hypothermia and fever control have been shown to improve neurological outcomes post cardiac
arrest. Common methods to induce hypothermia include body surface cooling and intravascular cooling; however, a
new approach using an esophageal cooling catheter has recently become available.
Methods: We report the first three cases of temperature control using an esophageal cooling device (ECD). The ECD
was placed in a similar fashion to orogastric tubes. Temperature reduction was achieved by connecting the ECD to a
commercially available external heat exchange unit (Blanketrol Hyperthermia – Hypothermia System).
Results: The first patient, a 54 year-old woman (86 kg) was admitted after resuscitation from an out-of-hospital
non-shockable cardiac arrest. Shortly after admission, she mounted a fever peaking at 38.3 °C despite administration of
cold intravenous saline and application of cooling blankets. ECD utilization resulted in a temperature reduction to
35.7 °C over a period of 4 h. She subsequently recovered and was discharged home at day 23. The second patient, a
59 year-old man (73 kg), was admitted after successful resuscitation from a protracted out-of hospital cardiac arrest.
His initial temperature was 35 °C, but slowly increased to 35.8 °C despite applying a cooling blanket and ice packs. The
ECD was inserted and a temperature reduction to 34.8 °C was achieved within 3 h. The patient expired on day 3. The
third patient, a 47 year-old man (95 kg) presented with a refractory fever secondary to necrotizing pneumonia in the
postoperative period after coronary artery bypass grafting. His fever persisted despite empiric antibiotics, antipyretics,
cooling blankets, and ice packs. ECD insertion resulted in a decrease in temperature from 39.5 to 36.5 °C in less than
5 h. He eventually made a favorable recovery and was discharged home after 59 days. In all 3 patients, device placement
occurred in under 3 min and ease-of-use was reported as excellent by nursing staff and physicians.
Conclusions: The esophageal cooling device was found to be an effective temperature control modality in this small
case series of critically ill patients. Preliminary data presented in this report needs to be confirmed in large randomized
controlled trials comparing its efficacy and safety to standard temperature control modalities.
Background
Uncontrolled fevers have been associated with poor neuro-
logical outcomes in various critically ill patient populations.
Post arrest anoxic brain injury, ischemic and hemorrhagic
strokes, and traumatic brain injury patients all appear to
be particularly sensitive to the detrimental effects of high
body temperature [1, 2]. Most authorities would therefore
recommend tight control of body temperature in these set-
tings [3–8].
Hypothermia is commonly induced using a combination
of internal and external cooling modalities. Internal cool-
ing modalities include intravenous administration of cold
crystalloids and intravascular cooling catheters [9]. Exter-
nal or body surface cooling can be achieved using cooling
blankets, adhesive pads, and ice packs [10]. Each of these
methods however, has its limitations [11, 12].
Administration of intravenous refrigerated crystalloid
(4 °C) boluses is a simple, effective and widely available
method of hypothermia induction [13]. Lack of precise
temperature control and the potential for pulmonary
edema however, make this modality unsuitable for the
maintenance phase of hypothermia [14, 15]. Surface cool-
ing methods, such as cooling blankets and ice packs, often
cause shivering, skin breakdown, and in obese patients
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may be ineffective [9]. Intravascular cooling catheters re-
quire the time of a physician for insertion and bear the po-
tential risks of line infection and deep venous thrombosis
[11, 12]. Searching for a temperature control modality that
overcomes the limitations, inefficiencies and inconve-
niences of the existing methods is therefore strongly
desired.
The ideal temperature control modality should be effect-
ive, safe, and easy to use. An esophageal cooling device has
recently become available which may theoretically possess
some of these attributes. We hereby report the first use of
this novel temperature control device in a series of three
critically ill patients.
Methods
The Esophageal Cooling Device® (Advanced Cooling Ther-
apy, Chicago, IL) is a cooling/warming device that connects
to standard heat exchange units. By design, it is a multi-
lumen, disposable, silicone tube (Fig. 1), placed in the
esophagus with its tip situated in the stomach. A central
inner lumen allows gastric drainage, while cold or warm
water circulate within an outer circumferential cavity.
Esophageal Cooling Device (ECD) models compatible with
the Blanketrol Hyper-Hypothermia System® (Cincinnati
Sub-Zero, Cincinatti, OH) and the Medi-Therm Hyper/
Hypothermia System® (Stryker, Kalamazoo, MI) are com-
mercially available.
Prior to ECD utilization, written informed consent was
obtained from the patients’ substitute decision makers.
Consent was also obtained to use patient information for
publication. Communication with the Health Sciences
Research Ethics Board of Western University revealed
that a board review prior to consent and publication is
not required. ECD’s are approved for clinical use by
Health Canada in addition to our local institutional regu-
latory bodies.
ECD placement technique was similar to that of stand-
ard orogastric tubes. After the appropriate depth of place-
ment was determined externally, the tip and proximal
shaft were lubricated with a water-soluble lubricant. The
ECD was then connected to the water-circulating heat
exchange unit, which was turned “on” allowing water to
flow through the device. This made the ECD stiffer facili-
tating subsequent esophageal advancement [16, 17]. Cor-
rect placement was then confirmed by chest X-ray.
As per the manufacturer’s recommendations, the central
(gastric) port was connected to a low level of intermittent
suction after initial ECD placement. The ECD product
monograph currently states that the gastric port is to be
used for suction only and should not be used for enteral
feeding. Communication with the manufacturer revealed
that the reason for this restriction was that an application
for approval was not sought to use this port for feeds.
After confirming adequate placement in a gastric location,
the authors felt that the benefits of using the gastric port
for enteral access outweigh the potential risks. The central
port was therefore subsequently used for enteral medica-
tion administration and trophic feeds in all three patients
off-label, uneventfully.
All patients were monitored with temperature-sensing
urinary catheters. The heat exchange unit (Blanketrol
Hyper-Hypothermia System) was set on “Auto Control”
mode. With this modality, the temperature of water circu-
lating through the system is automatically adjusted by the
heat exchange unit in order to match a chosen setpoint.
The operator in charge of regulating the target temperature
was the ICU nurse. Both bladder and target temperatures
were recorded hourly.
Our current institutional protocol for comatose post car-
diac arrest survivors aims at maintaining patient tempera-
tures in a range of 34 to 36 °C for a period of 24 h. The
induction protocol comprises the administration of 1 litre
boluses of refrigerated normal saline (at 4 °C), up to a max-
imum total of 4 litres. Additionally, our protocol allows for
the application of ice packs to the groin and axilla, and a
cooling blanket (Maxi-Therm® Lite Blankets, Cincinnati
Sub-Zero, Cincinatti, OH) directly to the patients skin dur-
ing the induction and maintenance phases of hypothermia.
All patients receive intravenous infusions of an opioid
Fig. 1 Esophageal cooling device. Esophageal cooling device
showing water inflow/outflow tubes and central (gastric) port
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(fentanyl or hydromorphone) and a hypnotic (midazolam
or popofol) during the 24 h of hypothermia. Use of neuro-
muscular blocking agents is left at the discretion of the
treating physician who may choose to reserve it’s use for
shivering treatment only. After 24 h of hypothermia, pas-
sive rewarming is initially attempted. Active rewarming
with a warming blanket is only used if the patient does not
rewarm passively within 6 h. Use of the ECD enabled
induction, maintenance and rewarming of our first two
patients. In our third patient, the ECD was used primarily
as a fever control modality.
Results
Patient A
A 54 year-old woman (86 kg, BMI 30.1) was transferred to
the critical care unit after successful resuscitation from an
out-of-hospital pulseless electrical activity (PEA) cardiac
arrest. Her past medical history was significant for severe
chronic obstructive pulmonary disease requiring home
oxygen. Post resuscitation, she remained comatose and a
seizure episode was witnessed in the ICU. Her temperature
rapidly increased to 38.3 °C one hour after admission,
upon which a cooling blanket was applied and 2 litres of
intravenous cold saline were administered. These interven-
tions resulted in only a mild reduction of temperature,
reaching 37.6 °C after 4 h (Fig. 2 a). At that point, an ECD
was placed to aid in temperature reduction.
After confirming adequate connection of the ECD to the
external heat exchange unit, we were able to induce
hypothermia despite the patient’s ongoing febrile response.
Patient temperature was reduced, from 37.6 to 35 °C,
within 6 h. During hypothermia induction, the cooling
blanket was kept on. After induction, the cooling blanket
was removed and hypothermia was maintained with the
ECD alone. The bedside nurse adjusted the external unit’s
temperature targets on more than one occasion. This was
noted to quickly reflect on the patient’s body temperature
(Fig. 2 a). After 26 h of ECD use, the device was removed.
Over the next few days, the patient showed signs of
neurological recovery. Due to her pre-existing respira-
tory disease however, weaning from mechanical ventila-
tion was prolonged. Extubation was achieved on day 16,
after which she made a full recovery and was discharged
home on day 23.
Patient B
A 59 year-old man (73 kg, BMI 23.8) was admitted to the
critical care unit after successful resuscitation from an
out-of-hospital PEA cardiac arrest. Return of spontaneous
circulation was obtained after 1 h from initiation of CPR.
Post resuscitation, the patient exhibited signs of cardio-
genic shock and pulmonary edema. ST elevation in the
lateral leads of his ECG led to an urgent coronary angio-
gram. This revealed no significant coronary artery disease
but severe mitral regurgitation was found. An intra-aortic
balloon pump was inserted and he was transferred to the
critical care unit on both epinephrine and norepinephrine
infusions.
His initial temperature on intensive care admission was
35 °C. No temperature interventions at that time were
therefore required. Approximately 7 h later, his temperature
slowly began to rise, despite the use of a cooling blanket
and the application of ice packs to his axilla and groin. At
that time, the patient's severe hypoxia due to acute pulmon-
ary edema, precluded the use of intravenous refrigerated
crystalloids for temperature reduction. The ECD was
therefore inserted for temperature modulation for the
remaining 17 h.
Despite the patient’s rising temperature trajectory, a re-
duction of temperature from 35.8 to 34.8 °C was achieved
within 3 h using the ECD (Fig. 2 b). Shivering was ob-
served and an intravenous bolus of cisatracurium was
given. The bedside nurse was allowed to adjust the exter-
nal unit’s temperature targets at her discretion to achieve
the desired patient temperature. On multiple occasions
however, the nurse turned the unit off after the patient
had reached target temperature assuming it was no longer
needed. After completing 24 h of hypothermia, rewarming
from 34.9 to 36.2 °C was achieved within 2 h using the
ECD. The unit was then turned off. Over the next few
hours the patient spiked a fever peaking at 39.1 °C, upon
which the heat exchange unit was turned on again and set
to a target of 36.5 °C. Over the next 3 h, the patient’s
temperature steadily approached target, coming down to
36.8 °C (Fig. 2 b). Unfortunately, the patient continued to
show signs of poor neurological prognosis during his crit-
ical care stay. A clinical diagnosis of post-anoxic brain
death was made on day 3.
Patient C
A 47 year-old man (95 kg, BMI 34.9) was admitted to the
intensive care unit for postoperative care after an emer-
gent coronary artery bypass grafting procedure. Preopera-
tively, he had experienced symptoms suggestive of a
respiratory tract infection with dyspnea, high-grade fevers
and leukocytosis. In the postoperative period, gradual
deterioration of his respiratory status was observed despite
empiric antibiotic therapy. On postoperative day 6, he
developed an acute respiratory distress syndrome and a
CT scan of the thorax revealed evidence of multifocal nec-
rotizing pneumonia. An increasing temperature refractory
to broad-spectrum antibiotic therapy, regular acetamino-
phen administration, cooling blankets, and application of
ice-packs to the groin and axilla triggered the insertion of
the ECD for fever control. His temperature at the time
was uncontrolled, peaking at 39.3 °C.
After insertion of the ECD, a temperature reduction
from 39.3 to 36.9 °C was achieved within 4 h. Over the
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next few hours, the patient’s temperature fluctuated
(Fig. 2 c), leading the nurse to change the set target ac-
cordingly. During the whole time the ECD was in place,
a cisatracurium infusion was ongoing for optimization of
mechanical ventilation. No evaluation of the device as a
potential trigger of shivering is therefore available for
this patient. His hospital stay was remarkable for sepsis-
induced multi-organ failure in addition to atrial and ven-
tricular arrhythmias that were observed since his admis-
sion. After a long stay in hospital, he eventually
recovered and was discharged home on postoperative
day 59.
Fig. 2 Patient temperatures after esophageal cooling device insertion in comparison to set targets. Top: Patient A. Middle: Patient B. Bottom: Patient C
Hegazy et al. BMC Anesthesiology  (2015) 15:152 Page 4 of 6
No complications directly attributable to the ECD were
observed for the three reported cases. The ECD required
less than three minutes for its placement to be successfully
completed. Ease-of-use was described as excellent by both
nurses and physicians.
Discussion
Our report is the first to describe the successful use of an
esophageal cooling device in humans. Insertion of this de-
vice was found to reliably decrease body temperature of crit-
ically ill patients refractory to standard cooling modalities.
On average, temperature reduction occurred at a rate of
0.52 °C/hr. This rate was significantly lower than that re-
ported in previous animal studies utilizing the ECD [18–20].
Kulstad et al. were the first to report esophageal cool-
ing in an animal study involving swine as large as 70 kg
in weight [18]. All swine were anesthetized with isoflur-
ane and endotracheally intubated. ECD utilization re-
sulted in an average cooling rate of 1.2 °C/hr. After 36 h
of continuous use, no histologic evidence of esophageal
mucosal damage was found. In addition, no shivering
was observed in any of their anesthetized swine during
ECD use. In our series however, shivering was observed
in one patient (patient B) in the absence of a cooling
blanket. Shivering is a very common side effect of sur-
face cooling techniques [21] and its avoidance is highly
desirable. Morbid effects of shivering include an increase
in myocardial oxygen consumption, lactic acidosis, and a
resistance to cooling, all of which can be deleterious in
the post cardiac arrest patient [22].
Anatomically, the esophagus is situated posterior to
the heart and major vessels. The ECD’s ability to modu-
late body temperature is therefore likely secondary to
heat transfer with the central circulation. The slower
cooling rate in our patients compared to previous animal
reports, might be due to multiple factors. Interspecies
differences are likely implicated. In addition, our patients
appeared to be actively mounting a fever at the time of
ECD utilization. Lastly, postcardiac arrest patients com-
monly have myocardial stunning and a low cardiac output.
This would likely result in a slower circulation impairing
systemic cooling. The average cooling rate observed with
the ECD in this series was however, comparable to re-
cently published cooling rates of other more commonly
used cooling devices. Endovascular cooling devices have
been recently reported to have an average cooling rate of
0.39 °C/hr, while surface cooling devices were reported to
have an average cooling rate of 0.27 °C/hr [23].
This method of cooling offers several advantages over the
currently available modalities. The esophageal-cooling de-
vice can be easily and quickly inserted upon patient arrival
to the ICU. Its small size does not interfere with bedside in-
terventions (e.g. line insertions, coronary angiograms) and
diagnostic studies. This is sharply contrasted to the use of
intravascular cooling catheters and cooling blankets. Intra-
vascular cooling catheters offer precise temperature control
but their insertion may be a source of time delay [24]. Cool-
ing blankets are generally patient-encompassing appliances
that can obstruct access to the patient for provision of care.
Consequently their application is frequently delayed until
other necessary interventions have been completed. Rapid
infusion of ice-cold saline is another alternative modality
that is frequently effective, but lacks precise temperature
control [12]. In addition, administration of large amounts
of fluids may be necessary to lower body temperature. This
bears the potential of inducing fluid overload and pulmon-
ary edema in certain at-risk patients. And lastly, the central
mechanism of cooling provided by the ECD may prove use-
ful for cooling of obese patients whose body habitus makes
conventional surface cooling techniques less effective [25].
Utilization of the esophageal environment for heat trans-
fer comes with significant limitations. The ECD is currently
approved for use for up to 36 h only, which limits the dur-
ation of temperature control this technique can provide. In
addition, esophageal exposure to intraluminal cold temper-
atures has been known to cause a reduction in esophageal
motility [26–29]. Further studies would be required to
evaluate if this reduction in esophageal motility is associ-
ated with morbidity (such as aspiration and/or infection).
Contraindications to ECD use include patients with known
esophageal deformity, evidence of esophageal trauma,
known ingestion of acidic or caustic poisons within the
prior 24 h and patients less than 40 kg in weight. Although
a potentially very useful tool, further data is needed to
characterize the patients that would benefit most from
ECD use, compare it with other temperature control mo-
dalities and delineate the possible associated adverse events.
Conclusions
The esophageal cooling device was found to be an effect-
ive temperature control modality in this small case series
of critically ill patients. Preliminary data presented in this
report needs to be confirmed in large randomized con-
trolled trials comparing its efficacy and safety to standard
temperature control modalities.
Key messages
 The esophageal cooling device (ECD) appears to be
an effective temperature control modality that can
be used for both cooling and rewarming.
 The average rate of cooling in this case series was
0.52 °C/hr.
 Shivering was observed in one out of the three
patients that were cooled with the ECD.
 Insertion of the device required less than 3 min and
ease-of-use was described as excellent by nursing
staff and physicians alike.
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